Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 1967-1972, June 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chirigos, M. A.
Right arrow Articles by Stylos, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chirigos, M. A.
Right arrow Articles by Stylos, W. A.

Immunomodulatory Effect of Various Molecular-Weight Maleic Anhydride-Divinyl Ethers and Other Agents in Vivo

Michael A. Chirigos1 and William A. Stylos

Virus and Disease Modification Section, Laboratory of Chemical Pharmacology, National Cancer Institute, NIH, Bethesda, Maryland 20205

Various molecular-weight maleic anhydride-divinyl ether copolymer polyanions were evaluated in six in vivo systems. Low- and high-molecular-weight MVE's were effective adjuvants with irradiated L1210 tumor cell vaccine. A high percentage of L1210-challenged survivors were refractory to a second challenge of tumor cells. Azimexon and Bacillus Calmette-Guérin were also effective adjuvants, but Bestatin was without adjuvant effect. All the MVE's demonstrated a marginal antitumor effect against the L1210 and LSTRA tumors. The MVE's, regardless of molecular weight differences, were effective in enhancing macrophage tumoricidal activity and retarding the development of M109 tumor growth in the lungs. Enhancement of delayed-type hypersensitivity by all six MVE's indicates their ability to stimulate T-cells.

1 To whom requests for reprints should be addressed.

Received 11/27/79. Accepted 3/11/80.




This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
L. Panaitescu and R. M. Ottenbrite
Biological Effects and Antitumor Activity Induced by Benzocaine Conjugated Anionic Polymers
Journal of Bioactive and Compatible Polymers, September 1, 2002; 17(5): 357 - 374.
[Abstract] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
W. Regelson
Review: Advances in Intraperitoneal (Intracavitary) Administration of Synthetic Polymers for Immunotherapy and Chemotherapy
Journal of Bioactive and Compatible Polymers, January 1, 1986; 1(1): 84 - 107.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.